RNA Supply Chain Solutions
-
mRNA Raw Materials: Supporting Your Journey To Market
12/5/2025
Implementing a quality-by-design approach for manufacturing inputs limits contamination risks and simplifies regulatory compliance. Validated processes ensure consistency when scaling operations.
-
Fit-For-Purpose And GMP Grade mRNA Reagents
3/24/2025
Ensure the safety and efficacy of your mRNA therapeutics with high-quality, GMP-grade reagents from a trusted partner with a multi-tiered quality approach to deliver manufacturing certainty.
-
jetMESSENGER®: mRNA Transfection Reagent For Hard-To-Transfect Cells
3/21/2023
Learn about a highly efficient and gentle mRNA transfection reagent designed for outstanding transfection efficiency in hard-to-transfect cells, finally allowing relevant gene expression experiments in almost all cell types.
-
Enabling mRNA Manufacturing For RNA-Based Vaccines And Therapeutics
2/9/2026
Learn about next-generation RNA polymerases that support diverse cap analog chemistries and modified nucleotides, ensuring high capping efficiency and sequence integrity for complex therapeutics.
-
Nanoplasmid™ Vector Platform
5/5/2026
With gene therapy advancing at a record pace, Aldevron recognizes the enormous promise your work can bring to therapeutics. We are proud to deliver a superior, modern plasmid technology to your therapeutic endeavors.
-
High-Fidelity Nuclease For Therapeutic Breakthroughs
10/28/2024
The hfCas12Max nuclease offers superior gene editing with high fidelity, broad PAM recognition, minimal off-target effects, and compatibility across cell types for therapeutic applications.
-
INDe sgRNAs For Preclinical Safety, Toxicity, And Efficacy Studies
11/29/2023
Seamlessly transition from discovery to delivery with INDe sgRNAs. These quality sgRNAs can be synthesized in quantities from milligrams to grams and follow high purity specifications.
-
Product Launch: Vaccinia Capping System mRNA Guanylyltransferase And mRNA Methyltransferase
12/5/2025
mRNA Vaccinia Capping System: Proven. Scalable. Tailored to the needs of biopharma companies developing mRNA-based therapies.
-
Process Chemicals For RNA Drug Manufacturing
Make use of our portfolio of raw materials required for mRNA with an integrated offering for all process steps, from plasmid DNA (pDNA) to mRNA synthesis to final formulation.
-
in vivo mRNA Delivery Using Liposome-Based Reagent
12/12/2022
in vivo-jetRNA®+ is a ready-to-use reagent that does not require formulation equipment that leads to 100% mRNA encapsulation leading to efficient mRNA delivery.